Patents
Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
02/2005
02/23/2005CN1585754A Quinazoline derivatives as antitumor agents
02/22/2005US6858733 Compounds for generating chemiluminescence with a peroxidase
02/17/2005WO2004084813A3 Chemical compounds
02/10/2005WO2005012281A1 Neuroprotective benzo[1,3]oxathol-2-ones
02/10/2005WO2005011700A1 INHIBITORS OF Akt ACTIVITY
02/10/2005US20050031899 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device
02/10/2005CA2534038A1 Inhibitors of akt activity
02/10/2005CA2533475A1 Neuroprotective benzo[1,3]oxathol-2-ones
02/03/2005US20050026934 Dissolved in water; recrystallized, dehydrated; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus, hepatitis virus
02/02/2005EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors
02/02/2005EP1501819A1 Estrogen receptor modulators
02/02/2005CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
01/2005
01/20/2005WO2005004606A2 Pyridinylanilides
01/19/2005EP1124562B1 Combination therapy to treat hepatitis b virus
01/19/2005CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
01/18/2005US6844441 Hypoglycemic agents; dietetics; gastrointestinal disorders; antidepressants; gastrointestinal disorders; antiinflammatory agents
01/13/2005US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer
01/13/2005US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
01/12/2005CN1564687A Use of phosphodiesterase IV inhibitors
01/12/2005CN1563002A Suitqable to industrialized method for preparing emtricitabine
01/06/2005WO2004076445A3 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
01/06/2005US20050004148 Human immunodeficiency and hepatitis B infections; high activity, low toxicity
01/06/2005US20050004104 Methods for the protection of memory and cognition
01/06/2005US20050004097 Indole derivatives
01/06/2005US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
01/04/2005US6837248 Reduced ignition propensity smoking article
12/2004
12/29/2004WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors
12/28/2004US6835844 Acrylic esters and use thereof
12/28/2004CA2226039C Pyridylfuran and pyridylthiophene compounds
12/16/2004WO2004108085A2 Methods for the protection of memory and cognition
12/16/2004US20040254201 Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties
12/16/2004CA2527114A1 Methods for the protection of memory and cognition
12/15/2004EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004CN1179945C Indole derivatives, process for preparation of same and use thereof
12/14/2004US6831174 Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties
12/14/2004CA2136075C Heterocyclic ether compounds that enhance cognitive function
12/08/2004CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004CN1178660C Antiviral combinations of lamivudine and adefovir
12/02/2004US20040242610 A cis isomer of 1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluorocytosine has potent activity against hepatitis B virus infection; administration by rectal, nasal, topical, transdermal, vaginal, parenteral, intravenous injection
12/01/2004EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004EP1246625B1 Uses and compositions of nitrate esters for providing sedation
11/2004
11/30/2004CA2075189C Method and compositions for the synthesis of bch-189 and related compounds
11/25/2004WO2004101519A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004WO2004101517A1 Carbazole derivative, organic semiconductor device, light-emitting device, and electronic device
11/25/2004WO2004100952A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opioid receptors ligands
11/25/2004US20040235905 preventing overload of Ca2+ ions in cells; ischemic heart diseases, ischemic cerebral diseases, ischemic renal diseases and in the protection of cells during thrombolytic therapy, angioplasty, bypass operation of coronary artery or organ transplantation and arrhythmias
11/25/2004US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004US20040234501 administering lamivudine; suppression reproduction of hepatitis virus; interferons
11/24/2004CN1549725A Hepatitis B virus proliferation inhibitor
11/23/2004CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/18/2004WO2004099195A1 3-carbonylaminothiophenes and their use as fungicides
11/18/2004CA2524508A1 3-carbonylaminothiophenes and their use as fungicides
11/17/2004EP1477186A1 Antipruritics
11/16/2004US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/10/2004EP1104415B1 Method of manufacture of 1,3-oxathiolane nucleosides
11/03/2004EP1473294A2 Substituted 1,3-oxathiolanes with antiviral properties
11/03/2004EP1456176A4 Improved compounds for generating chemiluminescence with a peroxidase
11/03/2004EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004CN1543463A Stereoselective methods for the preparation of nucleosides
11/03/2004CN1173705C Use of ª‰-2-hydroxymethyl-5-(5-fluctyosine-1-yl)-1,3-oxathialane in preparation of medicine and composition containing same
11/02/2004US6812233 Therapeutic nucleosides
10/2004
10/27/2004EP1471063A1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
10/27/2004EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/21/2004WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/21/2004CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/20/2004EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/13/2004EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/07/2004WO2004085432A1 Process and intermediates for preparing emtricitabine
10/07/2004WO2004084813A2 Chemical compounds
10/07/2004US20040198790 Triazole compound containing a phosphonate group
10/05/2004US6800656 Tricyclic compounds and method of treating herpes virus
09/2004
09/30/2004WO2004082619A2 Forms of 5-azacytidine
09/30/2004US20040192687 Dna-pk inhibitors
09/23/2004US20040186118 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
09/23/2004US20040186065 Forms of 5-azacytidine
09/22/2004EP1100781B1 High affinity ligands for nociceptin receptor orl-1
09/22/2004CN1167697C Benzopyran derivative
09/21/2004CA2033143C Alkyl esters of 5-heterocyclic-pyridine-2,3-dicarboxylate acids, 5-heterocyclic 2-(2-imidazoline-2-yl)pyridines, useful as herbicidal agents and methods for the preparation thereof
09/16/2004US20040180885 Indole derivatives, process for preparation of the same and use thereof
09/15/2004EP1456176A1 Improved compounds for generating chemiluminescence with a peroxidase
09/15/2004EP1370547B1 Benzoaxathiepin derivatives and their use as medicines
09/10/2004WO2004076445A2 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
09/10/2004WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004CA2516239A1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
09/09/2004US20040176599 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/07/2004US6787534 Sulfonamide-containing heterocyclic compounds
09/02/2004WO2004074280A1 Pyridine derivatives as fungicidal compounds
09/02/2004WO2004073619A2 Ccr8 antagonists
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171124 includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers; effective against human immunodeficiency virus (HIV), hepatitis B virus (HBV), and other viruses
09/01/2004EP1451164A2 Amide derivatives having improved solubility
09/01/2004CN1525966A New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias
08/2004
08/26/2004WO2004018438A3 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
08/26/2004US20040167334 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides
08/25/2004EP1449841A1 New fungicidal compounds
08/12/2004WO2004067524A1 Ep4 receptor antagonists
08/11/2004EP1444211A2 Quinazoline derivatives as antitumor agents
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 25